shutterstock_1416694388_dcstockphotography
3 November 2021PatentsMuireann Bolger

PTAB ‘almost always wrong’ on Fintiv trial dates, research reveals

The US Patent Trial and Appeal Board (PTAB)’s dependence on trial dates to help it determine whether to apply the controversial NHK-Fintiv rule to inter partes (IPR) review petitions is flawed, according to research.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
9 March 2022   The board designated no precedential opinions last year—will 2022 play out any different, asks Rick Bisenius of Fish & Richardson.
Patents
23 September 2021   Plans are unfolding for new legislation to erode the power of the US Patent Trial and Appeal Board to reject inter partes reviews under the controversial NHK-Fintiv rule, Senator Patrick Leahy has announced.
Patents
23 March 2021   Change is afoot at the US Patent Trial and Appeal Board and—to the chagrin of petitioners—the pendulum has swung decidedly in favour of patent owners.